Oura Hits $11 Billion Valuation After $900M Funding Boost to Redefine Wearable Health Tech
Oura announced Tuesday that it has secured over $900 million in a Series E funding round, pushing the Finnish wearable tech company’s valuation to an impressive $11 billion.
The round was led by Fidelity Management & Research Company, with new investor ICONIQ joining alongside existing backers Whale Rock and Atreides.
“With this funding, we’re accelerating innovation, broadening our global presence, and setting a new benchmark for how wearables can transform preventive health,” said Oura CEO Tom Hale.
Founded in 2015, Oura is best known for its Oura Ring, a sleek smart ring that tracks sleep, fitness, recovery, and health insights. The company has sold over 5.5 million rings to date, more than doubling from 2.5 million in mid-2024. Last year, Oura generated $500 million in revenue and now expects to surpass $1 billion in sales in 2025.
The brand competes directly with other smart ring makers like Samsung and RingConn, as well as fitness-focused devices such as Whoop and Garmin. To expand its reach, Oura has been rolling out new features aimed at competing with full-scale wearables like the Apple Watch.
Recent product launches include the Oura Ring 4 Ceramic and Health Panels, a blood testing tool that lets users schedule lab work and track up to 50 biomarkers inside the Oura app. Paired with its AI-powered Advisor, users receive personalized insights on lifestyle, diet, and activity.
Oura also teamed up with Dexcom, a global leader in glucose monitoring, to integrate blood sugar data with biometrics from the Oura Ring — allowing users to track glucose levels alongside sleep, stress, and activity metrics.
“We’re not just building a product — we’re driving a global movement toward proactive health,” Hale added. “Our mission is to help people understand their bodies, make smarter lifestyle choices, and stay more connected with their healthcare providers.”
